Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 24 |
NetGPI | no | yes: 0, no: 24 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0031974 | membrane-enclosed lumen | 2 | 2 |
GO:0031981 | nuclear lumen | 5 | 2 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 2 |
GO:0043233 | organelle lumen | 3 | 2 |
GO:0070013 | intracellular organelle lumen | 4 | 2 |
GO:0097014 | ciliary plasm | 5 | 2 |
GO:0099568 | cytoplasmic region | 3 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: E9AWY1
Term | Name | Level | Count |
---|---|---|---|
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0016567 | protein ubiquitination | 7 | 2 |
GO:0019538 | protein metabolic process | 3 | 2 |
GO:0032446 | protein modification by small protein conjugation | 6 | 2 |
GO:0036211 | protein modification process | 4 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0043412 | macromolecule modification | 4 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0070647 | protein modification by small protein conjugation or removal | 5 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 24 |
GO:0005509 | calcium ion binding | 5 | 18 |
GO:0043167 | ion binding | 2 | 24 |
GO:0043169 | cation binding | 3 | 24 |
GO:0046872 | metal ion binding | 4 | 24 |
GO:0003824 | catalytic activity | 1 | 2 |
GO:0004842 | ubiquitin-protein transferase activity | 4 | 2 |
GO:0016740 | transferase activity | 2 | 2 |
GO:0019787 | ubiquitin-like protein transferase activity | 3 | 2 |
GO:0061630 | ubiquitin protein ligase activity | 5 | 2 |
GO:0061659 | ubiquitin-like protein ligase activity | 4 | 2 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 340 | 344 | PF00656 | 0.453 |
CLV_C14_Caspase3-7 | 360 | 364 | PF00656 | 0.306 |
CLV_NRD_NRD_1 | 76 | 78 | PF00675 | 0.592 |
CLV_PCSK_KEX2_1 | 287 | 289 | PF00082 | 0.486 |
CLV_PCSK_KEX2_1 | 76 | 78 | PF00082 | 0.586 |
CLV_PCSK_PC1ET2_1 | 287 | 289 | PF00082 | 0.486 |
CLV_PCSK_SKI1_1 | 287 | 291 | PF00082 | 0.437 |
DEG_SPOP_SBC_1 | 95 | 99 | PF00917 | 0.681 |
DOC_CYCLIN_RxL_1 | 272 | 282 | PF00134 | 0.343 |
DOC_MAPK_gen_1 | 287 | 295 | PF00069 | 0.445 |
DOC_MAPK_MEF2A_6 | 62 | 71 | PF00069 | 0.497 |
DOC_PP1_RVXF_1 | 273 | 280 | PF00149 | 0.366 |
DOC_PP4_FxxP_1 | 123 | 126 | PF00568 | 0.732 |
DOC_USP7_MATH_1 | 163 | 167 | PF00917 | 0.780 |
DOC_USP7_MATH_1 | 182 | 186 | PF00917 | 0.661 |
DOC_USP7_MATH_1 | 216 | 220 | PF00917 | 0.481 |
DOC_USP7_MATH_1 | 95 | 99 | PF00917 | 0.706 |
DOC_WW_Pin1_4 | 102 | 107 | PF00397 | 0.604 |
DOC_WW_Pin1_4 | 122 | 127 | PF00397 | 0.751 |
DOC_WW_Pin1_4 | 136 | 141 | PF00397 | 0.722 |
DOC_WW_Pin1_4 | 180 | 185 | PF00397 | 0.700 |
DOC_WW_Pin1_4 | 279 | 284 | PF00397 | 0.421 |
DOC_WW_Pin1_4 | 96 | 101 | PF00397 | 0.553 |
LIG_14-3-3_CanoR_1 | 235 | 240 | PF00244 | 0.588 |
LIG_APCC_ABBA_1 | 253 | 258 | PF00400 | 0.381 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.588 |
LIG_CaM_IQ_9 | 68 | 83 | PF13499 | 0.329 |
LIG_FHA_1 | 13 | 19 | PF00498 | 0.476 |
LIG_FHA_2 | 280 | 286 | PF00498 | 0.364 |
LIG_FHA_2 | 338 | 344 | PF00498 | 0.453 |
LIG_LIR_Apic_2 | 21 | 26 | PF02991 | 0.349 |
LIG_LIR_Gen_1 | 245 | 255 | PF02991 | 0.338 |
LIG_LIR_Gen_1 | 326 | 335 | PF02991 | 0.377 |
LIG_LIR_Gen_1 | 350 | 358 | PF02991 | 0.343 |
LIG_LIR_Gen_1 | 386 | 392 | PF02991 | 0.427 |
LIG_LIR_Nem_3 | 224 | 229 | PF02991 | 0.555 |
LIG_LIR_Nem_3 | 245 | 250 | PF02991 | 0.496 |
LIG_LIR_Nem_3 | 252 | 257 | PF02991 | 0.379 |
LIG_LIR_Nem_3 | 308 | 312 | PF02991 | 0.438 |
LIG_LIR_Nem_3 | 326 | 331 | PF02991 | 0.430 |
LIG_LIR_Nem_3 | 350 | 354 | PF02991 | 0.352 |
LIG_LIR_Nem_3 | 386 | 390 | PF02991 | 0.379 |
LIG_LYPXL_yS_3 | 150 | 153 | PF13949 | 0.545 |
LIG_SH2_CRK | 247 | 251 | PF00017 | 0.469 |
LIG_SH2_CRK | 312 | 316 | PF00017 | 0.566 |
LIG_SH2_CRK | 328 | 332 | PF00017 | 0.260 |
LIG_SH2_GRB2like | 201 | 204 | PF00017 | 0.527 |
LIG_SH2_NCK_1 | 312 | 316 | PF00017 | 0.443 |
LIG_SH2_STAP1 | 247 | 251 | PF00017 | 0.469 |
LIG_SH2_STAT3 | 201 | 204 | PF00017 | 0.759 |
LIG_SH2_STAT3 | 212 | 215 | PF00017 | 0.646 |
LIG_SH3_3 | 225 | 231 | PF00018 | 0.627 |
LIG_SH3_3 | 97 | 103 | PF00018 | 0.601 |
LIG_SH3_4 | 314 | 321 | PF00018 | 0.592 |
LIG_SUMO_SIM_anti_2 | 25 | 31 | PF11976 | 0.421 |
LIG_SUMO_SIM_par_1 | 379 | 386 | PF11976 | 0.395 |
MOD_CDC14_SPxK_1 | 125 | 128 | PF00782 | 0.478 |
MOD_CDK_SPK_2 | 96 | 101 | PF00069 | 0.440 |
MOD_CDK_SPxK_1 | 122 | 128 | PF00069 | 0.480 |
MOD_CK1_1 | 104 | 110 | PF00069 | 0.566 |
MOD_CK1_1 | 131 | 137 | PF00069 | 0.710 |
MOD_CK1_1 | 202 | 208 | PF00069 | 0.776 |
MOD_CK1_1 | 221 | 227 | PF00069 | 0.683 |
MOD_CK1_1 | 53 | 59 | PF00069 | 0.189 |
MOD_CK1_1 | 96 | 102 | PF00069 | 0.625 |
MOD_CK2_1 | 299 | 305 | PF00069 | 0.381 |
MOD_CK2_1 | 380 | 386 | PF00069 | 0.412 |
MOD_GlcNHglycan | 133 | 136 | PF01048 | 0.756 |
MOD_GlcNHglycan | 165 | 168 | PF01048 | 0.676 |
MOD_GlcNHglycan | 177 | 180 | PF01048 | 0.808 |
MOD_GlcNHglycan | 184 | 187 | PF01048 | 0.582 |
MOD_GlcNHglycan | 204 | 207 | PF01048 | 0.525 |
MOD_GlcNHglycan | 261 | 264 | PF01048 | 0.403 |
MOD_GlcNHglycan | 296 | 300 | PF01048 | 0.365 |
MOD_GSK3_1 | 129 | 136 | PF00069 | 0.774 |
MOD_GSK3_1 | 163 | 170 | PF00069 | 0.739 |
MOD_GSK3_1 | 195 | 202 | PF00069 | 0.725 |
MOD_GSK3_1 | 295 | 302 | PF00069 | 0.363 |
MOD_GSK3_1 | 323 | 330 | PF00069 | 0.523 |
MOD_GSK3_1 | 50 | 57 | PF00069 | 0.508 |
MOD_GSK3_1 | 8 | 15 | PF00069 | 0.555 |
MOD_N-GLC_1 | 199 | 204 | PF02516 | 0.709 |
MOD_N-GLC_1 | 259 | 264 | PF02516 | 0.454 |
MOD_N-GLC_1 | 60 | 65 | PF02516 | 0.501 |
MOD_N-GLC_2 | 3 | 5 | PF02516 | 0.403 |
MOD_NEK2_1 | 295 | 300 | PF00069 | 0.303 |
MOD_NEK2_1 | 323 | 328 | PF00069 | 0.571 |
MOD_NEK2_2 | 380 | 385 | PF00069 | 0.411 |
MOD_NEK2_2 | 50 | 55 | PF00069 | 0.189 |
MOD_PIKK_1 | 140 | 146 | PF00454 | 0.682 |
MOD_PIKK_1 | 157 | 163 | PF00454 | 0.583 |
MOD_PIKK_1 | 188 | 194 | PF00454 | 0.834 |
MOD_PIKK_1 | 321 | 327 | PF00454 | 0.487 |
MOD_PKA_2 | 50 | 56 | PF00069 | 0.367 |
MOD_Plk_1 | 129 | 135 | PF00069 | 0.487 |
MOD_Plk_1 | 268 | 274 | PF00069 | 0.312 |
MOD_Plk_1 | 349 | 355 | PF00069 | 0.395 |
MOD_Plk_1 | 60 | 66 | PF00069 | 0.501 |
MOD_Plk_2-3 | 8 | 14 | PF00069 | 0.408 |
MOD_Plk_4 | 104 | 110 | PF00069 | 0.534 |
MOD_Plk_4 | 249 | 255 | PF00069 | 0.347 |
MOD_Plk_4 | 305 | 311 | PF00069 | 0.357 |
MOD_Plk_4 | 327 | 333 | PF00069 | 0.343 |
MOD_ProDKin_1 | 122 | 128 | PF00069 | 0.752 |
MOD_ProDKin_1 | 136 | 142 | PF00069 | 0.722 |
MOD_ProDKin_1 | 180 | 186 | PF00069 | 0.702 |
MOD_ProDKin_1 | 279 | 285 | PF00069 | 0.421 |
MOD_ProDKin_1 | 96 | 102 | PF00069 | 0.554 |
TRG_DiLeu_BaEn_1 | 350 | 355 | PF01217 | 0.454 |
TRG_ENDOCYTIC_2 | 150 | 153 | PF00928 | 0.737 |
TRG_ENDOCYTIC_2 | 226 | 229 | PF00928 | 0.512 |
TRG_ENDOCYTIC_2 | 247 | 250 | PF00928 | 0.493 |
TRG_ENDOCYTIC_2 | 328 | 331 | PF00928 | 0.459 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P229 | Leptomonas seymouri | 56% | 100% |
A0A0N1ILD7 | Leptomonas seymouri | 21% | 87% |
A0A0S4JBP2 | Bodo saltans | 25% | 88% |
A0A1X0NCU6 | Trypanosomatidae | 34% | 100% |
A0A1X0NTS2 | Trypanosomatidae | 25% | 88% |
A0A3Q8IMS6 | Leishmania donovani | 90% | 100% |
A0A3S7WWY0 | Leishmania donovani | 25% | 88% |
A0A3S7WYG1 | Leishmania donovani | 69% | 100% |
A4HDK3 | Leishmania braziliensis | 74% | 100% |
A4HDK4 | Leishmania braziliensis | 75% | 100% |
A4HZP7 | Leishmania infantum | 25% | 88% |
A4I0X7 | Leishmania infantum | 91% | 100% |
A4I0X8 | Leishmania infantum | 68% | 100% |
C9ZWH1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 28% | 100% |
E9AK36 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 31% | 100% |
E9AVK3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 23% | 100% |
E9AWY2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 69% | 100% |
O97201 | Leishmania major | 31% | 67% |
Q4QAJ2 | Leishmania major | 67% | 85% |
Q4QAJ3 | Leishmania major | 89% | 100% |
Q4QBX6 | Leishmania major | 25% | 88% |
V5B9E6 | Trypanosoma cruzi | 25% | 100% |
V5BK04 | Trypanosoma cruzi | 35% | 100% |